v3.26.3
CONSOLIDATED BALANCE SHEETS - Exascale Labs Inc [Member] - USD ($)
Jun. 30, 2026
Jun. 30, 2025
Current Assets    
Cash and cash equivalents $ 2,693,586 $ 4,231,689
U.S. Dollar Coin 2,160,746
Accounts receivable, net 1,107,210 152,536
Advance to suppliers 112,343 1,030,761
Refundable deposits receivable 450,000 681,125
Other receivables 1,207,626
Total Current Assets 6,523,885 7,303,737
Non-Current Assets    
Deferred offering costs 190,000
Equipment, net 12,840 19,600
Total Non-Current Assets 202,840 19,600
Total Assets 6,726,725 7,323,337
Current Liabilities    
Accounts payable 916,422 90,015
Simple agreements for future equity 29,121,268 18,243,885
Contract liabilities 1,070,378 432,760
Refundable deposits payable 359,481 1,445,580
Other current liabilities 417,951 107,481
Total current liabilities 31,885,500 20,319,721
Total liabilities 31,885,500 20,319,721
Shareholders’ Deficit    
Common stock, $0.0001 par value; 100 shares authorized; 100 shares issued and outstanding 15
Additional paid-in capital 220,636 220,636
Accumulated deficit (25,379,426) (13,217,035)
Total Stockholders’ Deficit (25,158,775) (12,996,384)
Total Liabilities and Stockholders’ Deficit 6,726,725 7,323,337
Common Stock Class A [Member]    
Shareholders’ Deficit    
Common stock, $0.0001 par value; 100 shares authorized; 100 shares issued and outstanding 3
Common Stock Class B [Member]    
Shareholders’ Deficit    
Common stock, $0.0001 par value; 100 shares authorized; 100 shares issued and outstanding $ 12